Lipoplex-Mediated Deintercalation of Doxorubicin from Calf Thymus DNA-Doxorubicin Complex

In this paper, we report the lipoplex-mediated deintercalation of anticancer drug doxorubicin (DOX) from the DOX-DNA complex under controlled experimental conditions. We used three zwitterionic liposomes, namely, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dimyristoyl-sn-glycero-3-phosph...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1992. - 32(2016), 35 vom: 06. Sept., Seite 8889-99
1. Verfasser: Das, Anupam (VerfasserIn)
Weitere Verfasser: Adhikari, Chandan, Chakraborty, Anjan
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Cations, Divalent DNA Adducts Liposomes Phosphatidylcholines doxorubicin-DNA 1,2-Dipalmitoylphosphatidylcholine 2644-64-6 Doxorubicin mehr... 80168379AG DNA 9007-49-2 calf thymus DNA 91080-16-9 Calcium SY7Q814VUP 1-palmitoyl-2-oleoylphosphatidylcholine TE895536Y5 Dimyristoylphosphatidylcholine U86ZGC74V5
LEADER 01000naa a22002652 4500
001 NLM262880407
003 DE-627
005 20231224202649.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.6b01860  |2 doi 
028 5 2 |a pubmed24n0876.xml 
035 |a (DE-627)NLM262880407 
035 |a (NLM)27465781 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Das, Anupam  |e verfasserin  |4 aut 
245 1 0 |a Lipoplex-Mediated Deintercalation of Doxorubicin from Calf Thymus DNA-Doxorubicin Complex 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 11.06.2018 
500 |a Date Revised 11.06.2018 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a In this paper, we report the lipoplex-mediated deintercalation of anticancer drug doxorubicin (DOX) from the DOX-DNA complex under controlled experimental conditions. We used three zwitterionic liposomes, namely, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), and 2-oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine (POPC), which are widely different in their phase transition temperatures to form a lipoplex with calf thymus DNA in the presence of Ca(2+) ions. The study revealed that DPPC being in sol-gel phase was more effective in releasing the drug from the DOX-DNA complex compared with liposomes that remain in liquid crystalline phase (DMPC and POPC). The higher extent of drug release in the case of DPPC liposomes was attributed to the stronger lipoplex formation with DNA as compared with that of other liposomes. Owing to the relatively smaller head group area, the DPPC liposomes in their sol-gel phase can absorb a larger number of Ca(2+) ions and hence offer a strong electrostatic interaction with DNA. This interaction was confirmed by time-resolved anisotropy and circular dichroism spectroscopy. Apart from the electrostatic interaction, the possible hydrophobic interaction between the liposomes and DNA was also taken into account for the observed deintercalation. The successful uptake of drug molecules by liposomes from the drug-DNA complex in the post-release period was also confirmed using confocal laser scanning microscopy (CLSM) 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Cations, Divalent  |2 NLM 
650 7 |a DNA Adducts  |2 NLM 
650 7 |a Liposomes  |2 NLM 
650 7 |a Phosphatidylcholines  |2 NLM 
650 7 |a doxorubicin-DNA  |2 NLM 
650 7 |a 1,2-Dipalmitoylphosphatidylcholine  |2 NLM 
650 7 |a 2644-64-6  |2 NLM 
650 7 |a Doxorubicin  |2 NLM 
650 7 |a 80168379AG  |2 NLM 
650 7 |a DNA  |2 NLM 
650 7 |a 9007-49-2  |2 NLM 
650 7 |a calf thymus DNA  |2 NLM 
650 7 |a 91080-16-9  |2 NLM 
650 7 |a Calcium  |2 NLM 
650 7 |a SY7Q814VUP  |2 NLM 
650 7 |a 1-palmitoyl-2-oleoylphosphatidylcholine  |2 NLM 
650 7 |a TE895536Y5  |2 NLM 
650 7 |a Dimyristoylphosphatidylcholine  |2 NLM 
650 7 |a U86ZGC74V5  |2 NLM 
700 1 |a Adhikari, Chandan  |e verfasserin  |4 aut 
700 1 |a Chakraborty, Anjan  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1992  |g 32(2016), 35 vom: 06. Sept., Seite 8889-99  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:32  |g year:2016  |g number:35  |g day:06  |g month:09  |g pages:8889-99 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.6b01860  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 32  |j 2016  |e 35  |b 06  |c 09  |h 8889-99